Using Cost-Effectiveness Analysis to Define a Breast Cancer Benefits Package for the Uninsured

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.74, Iss.2, 2002-07, pp. : 143-153

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Cost-effectiveness Analysis of Two Rehabilitation Support Services for Women with Breast Cancer

By Gordon Louisa

Breast Cancer Research and Treatment, Vol. 94, Iss. 2, 2005-11 ,pp. : 123-133

Springer Publishing Company

Access to resources Recommend Favorite

Trastuzumab in adjuvant breast cancer therapy. A model based cost-effectiveness analysis

By Norum J. Olsen J. A. Wist E. A. Lønning P. E.

Acta Oncologica, Vol. 46, Iss. 2, 2007-01 ,pp. : 153-164

Informa Healthcare

Access to resources Recommend Favorite

Cost-effectiveness analysis of colorectal cancer treatments

By van den Hout W.B. van den Brink M. Stiggelbout A.M. van de Velde C.J.H. Kievit J.

European Journal of Cancer, Vol. 38, Iss. 7, 2002-05 ,pp. : 953-963

Elsevier

Access to resources Recommend Favorite

Cost-Effectiveness of Letrozole in the Extended Adjuvant Treatment of Women with Early Breast Cancer

By Ouagari Khalid Karnon Jon Delea Thomas Talbot Willena Brandman Jane

Breast Cancer Research and Treatment, Vol. 101, Iss. 1, 2007-01 ,pp. : 37-49

Springer Publishing Company

Access to resources Recommend Favorite

Cost-effectiveness of HER2 testing and trastuzumab therapy for metastatic breast cancer

By Lidgren Mathias Wilking Nils Jonsson Bengt Rehnberg Clas

Acta Oncologica, Vol. 47, Iss. 6, 2008-08 ,pp. : 1018-1028

Informa Healthcare

Access to resources Recommend Favorite